Collegium Pharmaceutical, Inc financial data

Symbol
COLL on Nasdaq
Location
100 Technology Center Drive, Stoughton, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 114 % +2.06%
Quick Ratio 7.78 % +9.73%
Debt-to-equity 569 % +21.3%
Return On Equity 24.1 % -41%
Return On Assets 3.6 % -49.8%
Operating Margin 20.7 % -35.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.6M shares -1.98%
Common Stock, Shares, Outstanding 31.6M shares -1.95%
Entity Public Float 1.03B USD +39.2%
Common Stock, Value, Issued 41K USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 31.6M shares -2.13%
Weighted Average Number of Shares Outstanding, Diluted 39.4M shares -1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 757M USD +26.3%
Operating Income (Loss) 157M USD -18.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 80.9M USD -36.8%
Income Tax Expense (Benefit) 22.4M USD -43.1%
Net Income (Loss) Attributable to Parent 58.4M USD -34%
Earnings Per Share, Basic 1 USD/shares -32.5%
Earnings Per Share, Diluted 1 USD/shares -30.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 150M USD +285%
Marketable Securities, Current 136M USD +67.6%
Accounts Receivable, after Allowance for Credit Loss, Current 234M USD +2.4%
Inventory, Net 38.1M USD +0.05%
Other Assets, Current 2.74M USD +2848%
Assets, Current 614M USD +38.3%
Deferred Income Tax Assets, Net 102M USD +41.3%
Property, Plant and Equipment, Net 12.2M USD -16.2%
Operating Lease, Right-of-Use Asset 4.43M USD -28.2%
Intangible Assets, Net (Excluding Goodwill) 725M USD -23.4%
Goodwill 146M USD -0.02%
Other Assets, Noncurrent 2.34M USD -43.9%
Assets 1.61B USD -1.7%
Accounts Payable, Current 7.65M USD +143%
Employee-related Liabilities, Current 4.1M USD -5.31%
Accrued Liabilities, Current 51.5M USD +8.13%
Contract with Customer, Liability, Current 667K USD
Liabilities, Current 453M USD -1.41%
Contract with Customer, Liability, Noncurrent 9.28M USD -7.22%
Deferred Income Tax Liabilities, Net 54.2M USD -23.9%
Operating Lease, Liability, Noncurrent 4.5M USD -23.9%
Liabilities 1.33B USD -4.88%
Accumulated Other Comprehensive Income (Loss), Net of Tax 292K USD -25.7%
Retained Earnings (Accumulated Deficit) -118M USD +33.1%
Stockholders' Equity Attributable to Parent 275M USD +17.3%
Liabilities and Equity 1.61B USD -1.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 55.4M USD -10.6%
Net Cash Provided by (Used in) Financing Activities -25.2M USD +53.4%
Net Cash Provided by (Used in) Investing Activities -9.68M USD +46.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 40.6M shares +2.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 171M USD +163%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.7M USD +24.2%
Deferred Tax Assets, Valuation Allowance 6.5M USD +12.4%
Deferred Tax Assets, Gross 159M USD +53.8%
Operating Lease, Liability 6.81M USD -4.25%
Depreciation 4.3M USD +9.2%
Payments to Acquire Property, Plant, and Equipment 798K USD +40.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 58.3M USD -34.5%
Lessee, Operating Lease, Liability, to be Paid 7.9M USD -6.96%
Property, Plant and Equipment, Gross 27.9M USD +8.58%
Operating Lease, Liability, Current 1.37M USD +7.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +20.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD +20.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) -539K USD +87.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.09M USD -20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.75M USD +18.7%
Deferred Tax Assets, Operating Loss Carryforwards 26.6M USD -21.3%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 11.3M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.57M USD +5.57%
Additional Paid in Capital 615M USD +5.55%
Amortization of Intangible Assets 40.8M USD +12.3%
Deferred Tax Assets, Net of Valuation Allowance 152M USD +56.2%
Share-based Payment Arrangement, Expense 32.4M USD +19.4%
Interest Expense 79.3M USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%